Results 61 to 70 of about 39,899 (305)

Clear cell papillary cholangiocarcinoma: A case report with review of literature

open access: yesIndian Journal of Pathology and Microbiology, 2014
Clear cell papillary cholangiocarcinoma is a rare variant of intrahepatic cholangiocarcinoma with only nine reported cases in the literature. This tumor needs to be differentiated from clear cell variant of hepatocellular carcinoma and other metastatic ...
Rachna Khera   +3 more
doaj   +1 more source

Towards Simultaneous Segmentation of Liver Tumors and Intrahepatic Vessels via Cross-attention Mechanism [PDF]

open access: yesarXiv, 2023
Accurate visualization of liver tumors and their surrounding blood vessels is essential for noninvasive diagnosis and prognosis prediction of tumors. In medical image segmentation, there is still a lack of in-depth research on the simultaneous segmentation of liver tumors and peritumoral blood vessels. To this end, we collect the first liver tumor, and
arxiv  

Mass-forming intrahepatic cholangiocarcinoma presenting with painful obstructive hemobilia

open access: yesJournal of the Belgian Society of Radiology, 2014
We report a very rare case of acute obstructive hemobilia caused by bleeding of a mass-forming intrahepatic cholangiocarcinoma in a 75-year old man. The prompt complete emergency diagnosis was made by ultrasound and confirmed by MDCT.
B Coulier   +3 more
doaj   +1 more source

Characterisation of the immune-related transcriptome in resected biliary tract cancers [PDF]

open access: yes, 2017
Although biliary tract cancers (BTCs) are known to have an inflammatory component, a detailed characterisation of immune-related transcripts has never been performed.
Braconi, Chiara   +19 more
core   +3 more sources

Percutaneous transhepatic cholangiography and biliary drainage after liver transplantation: A five-year experience [PDF]

open access: yes, 1987
Evaluation of the biliary tract by percutaneous transhepatic cholangiography (PTC) is often required in liver transplant patients with an abnormal postoperative course.
AB Zajko   +27 more
core   +1 more source

Systemic therapies for intrahepatic cholangiocarcinoma [PDF]

open access: yesJournal of Hepatology, 2020
Intrahepatic cholangiocarcinoma (iCCA) is a highly lethal hepatobiliary neoplasm whose incidence is increasing. Largely neglected for decades as a rare malignancy and frequently misdiagnosed as carcinoma of unknown primary, considerable clinical and investigative attention has recently been focused on iCCA worldwide.
Robin Kate Kelley   +3 more
openaire   +4 more sources

Immunotyping the Tumor Microenvironment Reveals Molecular Heterogeneity for Personalized Immunotherapy in Cancer

open access: yesAdvanced Science, EarlyView.
This study develops TMEclassifier, a machine‐learning tool that classifies cancers into three distinct subtypes—Immune exclusive (IE), immune suppressive (IS), and immune activated (IA)—which exhibit significant heterogeneity and necessitate customized therapeutic strategies.
Dongqiang Zeng   +27 more
wiley   +1 more source

The roles of transforming growth factor-β, Wnt, Notch and hypoxia on liver progenitor cells in primary liver tumours [PDF]

open access: yes, 2014
Primary liver tumours have a high incidence and mortality. The most important forms are hepatocellular carcinoma and intrahepatic cholangiocarcinoma, both can occur together in the mixed phenotype hepatocellular-cholangiocarcinoma. Liver progenitor cells
Bogaerts, Eliene   +4 more
core   +1 more source

Consensus Conference on Intrahepatic Cholangiocarcinoma [PDF]

open access: yesHPB, 2015
Intrahepatic cholangiocarcinoma (ICC) is rising in incidence owing to improved recognition and a truly increased rate of the disease. Therefore, understanding the disease, its natural history and the impact of resection is critical for surgeons. The authors have succinctly reviewed the role of surgical intervention and acknowledged the controversies ...
Jean Francois H. Geschwind   +5 more
openaire   +3 more sources

Targeting GPX4 to Induce Ferroptosis Overcomes Chemoresistance Mediated by the PAX8‐AS1/GPX4 Axis in Intrahepatic Cholangiocarcinoma

open access: yesAdvanced Science, EarlyView.
PAX8‐AS1 drives chemoresistance in intrahepatic cholangiocarcinoma by activating NRF2‐mediated GPX4 transcription and stabilizing GPX4 mRNA via IGF2BP3. Targeting the PAX8‐AS1/GPX4 axis with a GPX4 inhibitor enhances the efficacy of gemcitabine and cisplatin in preclinical models, offering a promising strategy to overcome chemotherapy resistance in ...
Zhi‐Wen Chen   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy